Therma Bright Inc V.THRM

Alternate Symbol(s): TBRIF

Healthcare Medical Devices

Therma Bright Inc. is a developer and partner in a range of diagnostic and medical device technologies. It focuses on providing consumers and medical professionals with solutions that address medical and healthcare challenges. It is involved in developing, acquiring, manufacturing, and marketing proprietary healthcare and medical devices for the consumer and institutional marketplace. Its product offerings include Covid-19 diagnostic test product line, such as AcuVid COVID-19 Rapid Antigen Saliva Test and AcuVid COVID-19 Rapid Antibody Test; Sores & Bite Inflammation Therapy product line, such as InterceptCS Cold Sore Prevention System and TherOZap, and Muscle Pain & Blood Circulation Health Therapy product line, such as Venowave, which is a circulation booster designed to improve circulation in the lower extremities. The Venowave is a medical compression pump that is lightweight, compact, battery operated, designed to treat and alleviate the symptoms associated with poor circulation.

TSXV:THRM - Post by User

Therma Bright Inc > Saliva tests expected to be available " soon "

<< Previous

Bullboard Posts

Next >>

Comment by hemi3tcon Nov 05, 2021 11:08pm

162 Views

Post# 34095103

RE:Saliva tests expected to be available " soon "

It says the test is a saliva collection type test. So it is probably the swish and gargle saliva test developed by BC Health dept and already in use in several provinces.

juniorbullalive wrote:
TORONTO -- A saliva-based COVID-19 test is likely to be available this fall, say private and public health officials touting various methods under consideration across the country as lineups grow at COVID-19 assessment centres and cases emerge in newly reopened schools.

Public Health Ontario's chief of microbiology and laboratory science lists several issues to be resolved before broad provincial use but expects saliva collection will soon make it easier to detect infection, especially among children and others unable to tolerate a nasopharyngeal swab.

"I do foresee it being an option in the near term,".

"We're aiming in the space of weeks to months. Sometime later this fall looks very probable."